رياتاز ٢٠٠ ملغ

Country: Իսրայել

language: արաբերեն

source: Ministry of Health

active_ingredient:

ATAZANAVIR AS SULFATE 200 MG

MAH:

BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED

ATC_code:

J05AE08

pharmaceutical_form:

CAPSULES

administration_route:

PER OS

manufactured_by:

BRISTOL MAYERS SQUIBB COMPANY , USA

therapeutic_group:

ATAZANAVIR

therapeutic_indication:

Reyataz is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

authorization_date:

2009-06-01